Use of Immunomodulatory High-Dose Subcutaneous Immunoglobulin in Treatment of Opsoclonus Myoclonus Syndrome

Opsoclonus Myoclonus Syndrome (OMS) is a rare autoimmune condition resulting in abnormal eye movements, involuntary twitching of muscle groups, ataxia, irritability, and speech impairment.

Saved in:
Bibliographic Details
Published in:Journal of allergy and clinical immunology 2010-02, Vol.125 (2), p.AB142-AB142
Main Authors: Alle, D, El-Dahr, J.M
Format: Article
Language:English
Subjects:
Allergy and Immunology
Ataxia
Medical research
Medical treatment
Pediatrics
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Opsoclonus Myoclonus Syndrome (OMS) is a rare autoimmune condition resulting in abnormal eye movements, involuntary twitching of muscle groups, ataxia, irritability, and speech impairment.
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2009.12.558